- Maximize LINZESS
- Leverage strong commercial capabilities
- Advance robust GI pipeline and guanylate cyclase (GC) research
- Prioritize investments in key value drivers
New bowel drug Trulance will be available for patients later this quarter.
Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a weak on high relative volume candidate
TheStreet highlights 3 stocks pushing the drugs industry higher today.